Press Releases

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

Press Releases
min. read
June 28, 2022

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

IFN Neurologic is an innovative application to help clinicians better serve patients with neurological disorders and provide treatments in the functional neuroscience domain.

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program


The Institute of Functional Neuroscience, a world leading treatment and rehabilitation centre utilising the latest technologies in neuroplasticity research, and MetaCell, an innovative life science software company specialised in cutting-edge research software for major pharma, biotech, and academic institutions, have partnered to launch IFN Neurologic. This application will help clinicians to better serve patients with neurological disorders and provide treatments in the functional neuroscience domain. The application has been piloted with a limited number of clinics in 2021/2022, and now is made available to clinics and patients worldwide.

Affiliate Program 

Affiliate clinics will use for the first time IFN Neurologic to perform restorative neuroplasticity interventions on their patients at their own clinic. The affiliate program includes a comprehensive education program accredited by IFN (Institute of Functional Neuroscience) and AICN (Australian Institute of Clinical Neuroscience), all the necessary hardware/software, and access to the IFN Neurologic platform.

Advanced neuroscience in the clinic

For over a decade, IFN has been at the forefront of neurology, advancing a series of techniques known as “applied neuroplasticity” to treat a range of neurological conditions, even severe cases that would typically have a poor prognosis in a traditional care setting. The team analyzes many different types of data, including quantitative electroencephalography (qEEG), MRI, blood samples, and cognitive tests to arrive at a personalised treatment strategy for each patient.  Some of their more advanced treatments involve highly targeted stimulation via lasers and/or magnets to help correct aberrant signalling patterns that underlie patients’ neurocognitive symptoms. Much like in the process of drug discovery, the IFN begins by establishing a dose-response curve to safely optimise the therapeutic outcome for each patient. The team has continued to publish positive results and is affiliated with researchers at some of the top academic institutions in the world.

Harnessing the power of cloud computing

With the emergence of Electronic Medical Records (EMR), patient diagnostic and treatment history is becoming increasingly accessible for doctors to review and analyze. Recognizing the opportunity to get more out of their EMR data and to scale up their diagnostic processes, IFN has partnered with MetaCell to develop a novel cloud-based functional neuroscience portal. This healthcare software-as-a-service approach automates many of the processes of organizing patient data and performing analyses on a wide range of neurological data points for each patient. Furthermore, it allows practitioners to collaborate around the care of each patient more efficiently with actionable data and reports.

The team

Dr. Randy Beck, PhD, Director of the IFN, said: “We’re excited to be launching this new application in partnership with MetaCell. With this new software that requires no installation and can be reached from any web browser in the world, we now have the ability to rapidly scale up our diagnostic processes and reach more patients around the world at the click of a button.”

Giovanni Idili, COO of MetaCell, added: “We are very proud to work with Dr. Beck and provide IFN with a solution that ultimately allows the organisation to help a much greater number of patients at the same outstanding level of service, and we look forward to partnering with many more clinical innovators using our unique approach to custom software development in concert with our clinical neuroscience platforms.”

About IFN

The Institute of Functional Neuroscience (IFN) utilises the latest in neuroplasticity and neuroscience research to develop treatment approaches aimed at improving brain and nervous system performance of patients with a wide range of conditions including migraines, seizure disorders, strokes, attention deficit disorders, obsessive compulsive disorder, developmental coordination delay, vertigo, depression, learning and developmental disorders, concussion syndromes and autism.

About MetaCell

MetaCell is a life science-focused software company composed of scientists and software engineers, with deep domain expertise in computational neuroscience, molecular biology, data science, and enterprise-grade online software development. Their solutions have been trusted for over a decade by some of the world's largest pharmaceutical companies and leading research institutions in the USA, UK, Australia, Canada, and Europe, including Biogen, Pfizer, Eisai, Salk, UCL, Mount Sinai, UCSD, Yale, Princeton, and many more.

Contact details

IFN Neurologic: | +61 (08) 6254 2282 |

IFN: | +61 (08) 6254 2282 |

MetaCell: | US +1 617-286-4832 | UK +44 1865 648684 |

Share this post online